Vanillin mediated green synthesis and application of gold nanoparticles for reversal of antimicrobial resistance in
Antibiotic potentiation
Extreme drug resistance (XDR)
Materials science
MexAB-OprM efflux pump
Microbiology
Nanotechnology
Pseudomonas aeruginosa
Vanillin
Vanillin capped gold nanoparticles (VAuNPs)
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
30
03
2019
revised:
24
05
2019
accepted:
27
06
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
18
7
2019
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) is a serious concern in pathogenic bacteria. As a new approach to addressing AMR, we report here the green synthesis of vanillin capped gold nanoparticles (VAuNPs) using the popular flavouring molecule vanillin (C
Identifiants
pubmed: 31312733
doi: 10.1016/j.heliyon.2019.e02021
pii: S2405-8440(19)35681-6
pii: e02021
pmc: PMC6609825
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e02021Références
J R Soc Med. 2002;95 Suppl 41:22-6
pubmed: 12216271
Antimicrob Agents Chemother. 2002 Oct;46(10):3133-41
pubmed: 12234835
J Med Microbiol. 2003 May;52(Pt 5):403-8
pubmed: 12721316
Antimicrob Agents Chemother. 2004 May;48(5):1797-802
pubmed: 15105137
FEMS Microbiol Lett. 2005 Feb 1;243(1):125-31
pubmed: 15668010
FEMS Microbiol Lett. 2006 Jan;254(2):217-25
pubmed: 16445748
Clin Microbiol Rev. 2006 Apr;19(2):382-402
pubmed: 16614254
J Antimicrob Chemother. 2007 Jun;59(6):1247-60
pubmed: 17145734
J Antimicrob Chemother. 2007 Mar;59(3):378-86
pubmed: 17289770
Ann Med. 2007;39(3):162-76
pubmed: 17457715
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Antimicrob Agents Chemother. 2009 May;53(5):2209-11
pubmed: 19258278
Nat Prod Rep. 2009 Jun;26(6):746-57
pubmed: 19471683
J Am Chem Soc. 2010 Sep 8;132(35):12349-56
pubmed: 20707350
Trends Microbiol. 2011 Aug;19(8):419-26
pubmed: 21664819
Langmuir. 2011 Sep 6;27(17):11098-105
pubmed: 21728302
Appl Microbiol Biotechnol. 2011 Oct;92(2):381-92
pubmed: 21881891
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Sep;95:354-68
pubmed: 22542395
J Antimicrob Chemother. 2012 Oct;67(10):2401-8
pubmed: 22807321
Nanoscale. 2013 Mar 7;5(5):1882-93
pubmed: 23348618
Open Microbiol J. 2013 Mar 22;7:72-82
pubmed: 23589748
Nanoscale. 2013 Sep 21;5(18):8340-50
pubmed: 23893008
J Clin Diagn Res. 2014 Oct;8(10):DC04-7
pubmed: 25478340
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Front Microbiol. 2015 Apr 28;6:377
pubmed: 25972857
Int J Nanomedicine. 2015 Aug 05;10:5025-34
pubmed: 26346483
Respirology. 2016 Feb;21(2):329-37
pubmed: 26711802
Antimicrob Agents Chemother. 2016 Jan 04;60(3):1767-78
pubmed: 26729493
Trends Biotechnol. 2016 Jun;34(6):440-449
pubmed: 26948438
Neurochem Res. 2016 Aug;41(8):1899-910
pubmed: 27038927
Microb Pathog. 2016 Oct;99:95-100
pubmed: 27521228
Sci Rep. 2016 Dec 20;6:38692
pubmed: 27995961
Oxid Med Cell Longev. 2016;2016:9734816
pubmed: 28077989
Avicenna J Med Biotechnol. 2017 Jan-Mar;9(1):2-7
pubmed: 28090273
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28533232
Nanoscale Res Lett. 2017 Dec;12(1):454
pubmed: 28709374
BMC Complement Altern Med. 2017 Aug 14;17(1):405
pubmed: 28806947
Sci Rep. 2017 Aug 25;7(1):9470
pubmed: 28842631
J Biol Chem. 2017 Dec 29;292(52):21243-21252
pubmed: 29097552
Microb Pathog. 2017 Dec;113:265-268
pubmed: 29107747
Sci Rep. 2017 Nov 8;7(1):15086
pubmed: 29118444
Front Microbiol. 2018 May 04;9:823
pubmed: 29780364
Nature. 2018 Jul;559(7713):259-263
pubmed: 29973719
Int J Mol Sci. 2018 Jul 06;19(7):null
pubmed: 29986450
Sci Rep. 2018 Jul 23;8(1):11029
pubmed: 30038318
J Infect Dis. 1978 Feb;137(2):122-30
pubmed: 627734
Antimicrob Agents Chemother. 1998 Apr;42(4):744-8
pubmed: 9559776